The FDA approved a new ketamine (KETARx, PharmaTher) for the treatment of surgical pain management. The FDA previously issued a pair of complete response letters for the application in 2024, citing ...

There remains a need for organizations and stakeholders to develop guidance for prescribing ketamine as a pain treatment.

An overview of the topics to be most important published in the past year, at the 2025 annual meeting of the Society for Ambulatory Anesthesia.

This monograph details the clinical efficacy and safety of TNX-102 SL, a sublingual formulation of cyclobenzaprine that targets nonrestorative sleep and modulates centralized pain, as a treatment for ...

Anesthesiology News, now in its 48th year, has been the most widely read publication for the specialty for the last 25 years.

1. Should regional anesthesia and nerve blocks be standardized, considering the current lack of standards compared with the well-defined guidelines for general anesthesia administration, which ...

Saline “flush” bags could be an underappreciated source of bacterial contamination that could potentially expose patients to pathogens.